Morningstar
MORN Nasdaq Financial Exchanges & Data Financials FY2016βFY2025
Morningstar's revenue rose 7.5% to $2.4 billion in fiscal 2025. Its operating margin was 21.5%, up from 21.3% a year earlier. Free cash flow was $443 million, down 1.4%. It paid out $864 million in dividends and buybacks, 195% of free cash flow. The diluted share count fell 2.1%.
What Morningstar does
No business description yet.
- Legal name
- MORNINGSTAR, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001289419-26-000013
0001289419
Revenue and margins
Morningstar had $2.4B of revenue in fiscal 2025, up 7.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $443M in fiscal 2025, 18.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Morningstar returned $864M to shareholders in fiscal 2025, 195% of free cash flow. The diluted share count fell 2.1%.
Value Morningstar yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$544M and divides by 42.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 21.4x Β· peers 25.8x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Morningstar can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $546M | $415M | $389M | $551M | $529M |
| Debt incl. finance leases | $359M | $1.1B | $972M | $699M | $1.1B |
| Net debt / EBITDA | β0.5x | 2.1x | 1.4x | 0.2x | 0.8x |
| Debt / equity | 0.3x | 0.9x | 0.7x | 0.4x | 0.9x |
| Interest coverage | 24.7x | 5.9x | 4.0x | 10.2x | 14.1x |
| Current ratio | 1.1x | 0.9x | 0.9x | 1.1x | 1.0x |
| Quick ratio | 1.1x | 0.9x | 0.9x | 1.1x | 1.0x |
| Total assets | $2.9B | $3.5B | $3.4B | $3.5B | $3.6B |
| Total liabilities | $1.4B | $2.3B | $2.1B | $1.9B | $2.4B |
| Shareholders' equity | $1.4B | $1.2B | $1.3B | $1.6B | $1.2B |
| Net debt (β = net cash) | β$187M | $695M | $583M | $148M | $544M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$15.7M
1 insider
Of sales under plans
100%
$15.7M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 5,659 | $218.84 | $1.2M | Form 4 |
| Aug 21, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 4,095 | $216.76 | $0.9M | Form 4 |
| Aug 20, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $214.16 | $1.6M | Form 4 |
| Aug 19, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 6,594 | $213.75 | $1.4M | Form 4 |
| Aug 18, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,906 | $210.26 | $1.7M | Form 4 |
| Aug 17, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $207.04 | $1.5M | Form 4 |
| Aug 14, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $206.88 | $1.5M | Form 4 |
| Aug 13, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $197.92 | $1.4M | Form 4 |
| Aug 12, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $195.27 | $1.4M | Form 4 |
| Aug 11, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 974 | $200.32 | $0.2M | Form 4 |
| Aug 10, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $201.84 | $1.5M | Form 4 |
| Aug 7, 2026 | Joseph D MansuetoExecutive Chairman, Director, 10% owner | Sold plan | 7,250 | $199.62 | $1.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 8 / 9 | 6 / 9 |
| Accruals ratio | β5.1% | β6.4% | β6.0% |
| Altman Z'' | 2.54 | 3.64 | 3.50 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Morningstar MORN | $8.6B | 7.5% | 21.5% | 18.1% | 22.5% | 21.4x | 6 | |
| FactSet FDS | $12.1B | 6.7% | 28.3% | 28.6% | 18.2% | 22.7x | 6 | Compare β |
| MSCI MSCI | $44.5B | 9.8% | 54.7% | 49.4% | 44.5% | 32.6x | 7 | Compare β |
| Cboe Global Markets CBOE | $35.7B | 15.1% | 31.1% | 35.7% | 22.8% | 26.5x | 9 | Compare β |
| CME Group CME | $109.6B | 6.4% | 64.9% | 64.3% | 11.9% | 25.1x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $799M | $912M | $1.0B | $1.2B | $1.4B | $1.7B | $1.9B | $2.0B | $2.3B | $2.4B |
| Gross profit | $454M | $525M | $609M | $696M | $833M | $1.0B | $1.1B | $1.2B | $1.4B | $1.5B |
| Operating income | $181M | $170M | $216M | $190M | $215M | $257M | $168M | $231M | $485M | $527M |
| Interest expense | $1.2M | $5.4M | $3.7M | $11.0M | $11.1M | $10.4M | $28.4M | $58.4M | $47.4M | $37.3M |
| Pretax income | $225M | $181M | $233M | $199M | $283M | $251M | $131M | $174M | $474M | $496M |
| Income tax | $63.7M | $42.9M | $47.8M | $45.6M | $59.7M | $62.6M | $56.5M | $33.0M | $104M | $122M |
| Net income | $161M | $137M | $183M | $152M | $224M | $193M | $70.5M | $141M | $370M | $374M |
| Diluted EPS | $3.72 | $3.18 | $4.25 | $3.52 | $5.18 | $4.45 | $1.64 | $3.29 | $8.58 | $8.87 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $214M | $250M | $315M | $334M | $384M | $450M | $298M | $316M | $592M | $590M |
| Capital expenditure | $62.8M | $66.6M | $76.1M | $80.0M | $76.7M | $102M | $130M | $119M | $143M | $147M |
| Free cash flow | $151M | $184M | $239M | $254M | $308M | $348M | $168M | $197M | $449M | $443M |
| Depreciation and amortization | $70.7M | $91.2M | $96.7M | $118M | $140M | $151M | $167M | $185M | $190M | $190M |
| Stock-based compensation | $14.5M | $24.1M | $31.7M | $44.4M | $36.6M | $41.9M | $83.2M | $52.8M | $54.7M | $56.4M |
| Acquisitions | $192M | $1.0M | $0.4M | $682M | $67.8M | $24.8M | $647M | $0.8M | $0.0M | $39.0M |
| Share buybacks | $48.8M | $42.3M | $20.9M | $4.9M | $41.9M | $1.3M | $226M | $1.4M | $11.6M | $787M |
| Dividends paid | $37.9M | $39.3M | $42.6M | $47.8M | $51.4M | $54.2M | $61.5M | $63.9M | $69.3M | $76.9M |
| Dividends and buybacks | $86.7M | $81.6M | $63.5M | $52.7M | $93.3M | $55.5M | $288M | $65.3M | $80.9M | $864M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $304M | $353M | $396M | $368M | $464M | $546M | $415M | $389M | $551M | $529M |
| Total debt | β | β | $70.0M | $513M | $449M | $359M | $1.1B | $972M | $699M | $1.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $472M | $530M | $602M | $603M | $730M | $888M | $811M | $816M | $1.0B | $1.0B |
| Current liabilities | $295M | $323M | $363M | $496M | $627M | $784M | $883M | $881M | $967M | $1.1B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $152M | $147M | $144M | $155M | $155M | $172M | $199M | $208M | $219M | $232M |
| Total assets | $1.4B | $1.4B | $1.5B | $2.4B | $2.7B | $2.9B | $3.5B | $3.4B | $3.5B | $3.6B |
| Total liabilities | $654M | $601M | $519M | $1.3B | $1.4B | $1.4B | $2.3B | $2.1B | $1.9B | $2.4B |
| Shareholders' equity | $697M | $805M | $935M | $1.1B | $1.3B | $1.4B | $1.2B | $1.3B | $1.6B | $1.2B |
| Margins | ||||||||||
| Gross margin | 56.9% | 57.6% | 59.7% | 59.0% | 60.0% | 58.9% | 58.3% | 58.6% | 60.6% | 61.0% |
| Operating margin | 22.6% | 18.6% | 21.2% | 16.1% | 15.5% | 15.1% | 9.0% | 11.3% | 21.3% | 21.5% |
| EBITDA margin | 31.5% | 28.6% | 30.6% | 26.1% | 25.5% | 24.0% | 17.9% | 20.4% | 29.7% | 29.3% |
| Net margin | 20.2% | 15.0% | 17.9% | 12.9% | 16.1% | 11.4% | 3.8% | 6.9% | 16.3% | 15.3% |
| FCF margin | 18.9% | 20.1% | 23.4% | 21.6% | 22.1% | 20.5% | 9.0% | 9.7% | 19.7% | 18.1% |
| Returns | ||||||||||
| Return on capital | β | β | β | 15.9% | 13.7% | 15.5% | 6.1% | 9.8% | 20.6% | 22.5% |
| Return on capital employed | 20.3% | 15.9% | 19.9% | 12.8% | 10.9% | 12.4% | 7.2% | 9.0% | 19.0% | 20.6% |
| Return on equity | 24.1% | 18.2% | 21.0% | 15.1% | 19.0% | 14.4% | 5.4% | 11.1% | 25.1% | 26.4% |
| Return on assets | 13.5% | 9.9% | 12.8% | 8.0% | 8.8% | 7.0% | 2.2% | 4.1% | 10.6% | 10.5% |
| Growth | ||||||||||
| Revenue growth | 1.2% | 14.2% | 11.9% | 15.6% | 17.9% | 22.3% | 10.1% | 9.0% | 11.6% | 7.5% |
| Net income growth | 21.4% | β15.0% | 33.7% | β16.9% | 47.1% | β13.6% | β63.5% | 100.1% | 162.2% | 1.2% |
| EPS growth | 24.0% | β14.5% | 33.7% | β17.2% | 47.2% | β14.1% | β63.2% | 100.6% | 160.8% | 3.4% |
| FCF growth | β18.1% | 21.6% | 30.1% | 6.6% | 20.9% | 13.2% | β51.7% | 17.2% | 127.5% | β1.4% |
| Share count change | β2.3% | β0.7% | 0.0% | 0.5% | 0.0% | 0.5% | β1.2% | 0.0% | 0.5% | β2.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β1.0x | 0.5x | β0.0x | β0.5x | 2.1x | 1.4x | 0.2x | 0.8x |
| Debt / equity | β | β | 0.1x | 0.5x | 0.4x | 0.3x | 0.9x | 0.7x | 0.4x | 0.9x |
| Interest coverage | 150.7x | 31.4x | 58.3x | 17.2x | 19.4x | 24.7x | 5.9x | 4.0x | 10.2x | 14.1x |
| Current ratio | 1.6x | 1.6x | 1.7x | 1.2x | 1.2x | 1.1x | 0.9x | 0.9x | 1.1x | 1.0x |
| Quick ratio | 1.6x | 1.6x | 1.7x | 1.2x | 1.2x | 1.1x | 0.9x | 0.9x | 1.1x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.9% | 7.3% | 7.5% | 6.8% | 5.5% | 6.0% | 6.9% | 5.8% | 6.3% | 6.0% |
| Stock comp / revenue | 1.8% | 2.6% | 3.1% | 3.8% | 2.6% | 2.5% | 4.5% | 2.6% | 2.4% | 2.3% |
| Payouts / FCF | 57.5% | 44.5% | 26.6% | 20.7% | 30.3% | 15.9% | 170.8% | 33.1% | 18.0% | 195.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | 4.0 | 6.0 | 5.0 | 5.0 | 8.0 | 8.0 | 6.0 |
| Altman Z'' | 5.0 | 5.4 | 6.5 | 3.4 | 3.4 | 3.6 | 2.2 | 2.5 | 3.6 | 3.5 |
| Accruals ratio | β4.4% | β8.2% | β9.2% | β9.5% | β6.3% | β9.2% | β7.2% | β5.1% | β6.4% | β6.0% |
Source: SEC EDGAR XBRL filings (CIK 0001289419). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.